Oshima Y - Search Results

1

Investigation of the role of CD1d-restricted invariant NKT cells in experimental choroidal neovascularization.

Hijioka K, Sonoda KH, Tsutsumi-Miyahara C, Fujimoto T, Oshima Y, Taniguchi M, Ishibashi T. Hijioka K, et al. Among authors: oshima y. Biochem Biophys Res Commun. 2008 Sep 12;374(1):38-43. doi: 10.1016/j.bbrc.2008.06.080. Epub 2008 Jul 9. Biochem Biophys Res Commun. 2008. PMID: 18606153

2

The antidepressant hypericin inhibits progression of experimental proliferative vitreoretinopathy.

Tahara YR, Sakamoto TR, Oshima YR, Ishibashi TR, Inomata HR, Murata TR, Hinton DR, Ryan SJ. Tahara YR, et al. Among authors: oshima yr. Curr Eye Res. 1999 Oct;19(4):323-9. doi: 10.1076/ceyr.19.4.323.5302. Curr Eye Res. 1999. PMID: 10520228

3

Targeted gene transfer to corneal stroma in vivo by electric pulses.

Oshima Y, Sakamoto T, Hisatomi T, Tsutsumi C, Sassa Y, Ishibashi T, Inomata H. Oshima Y, et al. Exp Eye Res. 2002 Feb;74(2):191-8. doi: 10.1006/exer.2001.1117. Exp Eye Res. 2002. PMID: 11950229

4

Critical role of photoreceptor apoptosis in functional damage after retinal detachment.

Hisatomi T, Sakamoto T, Goto Y, Yamanaka I, Oshima Y, Hata Y, Ishibashi T, Inomata H, Susin SA, Kroemer G. Hisatomi T, et al. Among authors: oshima y. Curr Eye Res. 2002 Mar;24(3):161-72. doi: 10.1076/ceyr.24.3.161.8305. Curr Eye Res. 2002. PMID: 12221523

5

Effects of dioxin on vascular endothelial growth factor (VEGF) production in the retina associated with choroidal neovascularization.

Takeuchi A, Takeuchi M, Oikawa K, Sonoda KH, Usui Y, Okunuki Y, Takeda A, Oshima Y, Yoshida K, Usui M, Goto H, Kuroda M. Takeuchi A, et al. Among authors: oshima y. Invest Ophthalmol Vis Sci. 2009 Jul;50(7):3410-6. doi: 10.1167/iovs.08-2299. Epub 2009 Jan 31. Invest Ophthalmol Vis Sci. 2009. PMID: 19182260

6

Antiangiogenic immunotherapy targeting Flk-1, DNA vaccine and adoptive T cell transfer, inhibits ocular neovascularization.

Zhang H, Sonoda KH, Hijioka K, Qiao H, Oshima Y, Ishibashi T. Zhang H, et al. Among authors: oshima y. Biochem Biophys Res Commun. 2009 Apr 17;381(4):471-476. doi: 10.1016/j.bbrc.2009.01.178. Biochem Biophys Res Commun. 2009. PMID: 19340941

7

Comprehensive analysis of inflammatory immune mediators in vitreoretinal diseases.

Yoshimura T, Sonoda KH, Sugahara M, Mochizuki Y, Enaida H, Oshima Y, Ueno A, Hata Y, Yoshida H, Ishibashi T. Yoshimura T, et al. Among authors: oshima y. PLoS One. 2009 Dec 4;4(12):e8158. doi: 10.1371/journal.pone.0008158. PLoS One. 2009. PMID: 19997642 Free PMC article.

8

Choroidal neovascularization enhanced by Chlamydia pneumoniae via Toll-like receptor 2 in the retinal pigment epithelium.

Fujimoto T, Sonoda KH, Hijioka K, Sato K, Takeda A, Hasegawa E, Oshima Y, Ishibashi T. Fujimoto T, et al. Among authors: oshima y. Invest Ophthalmol Vis Sci. 2010 Sep;51(9):4694-702. doi: 10.1167/iovs.09-4464. Epub 2010 Apr 14. Invest Ophthalmol Vis Sci. 2010. PMID: 20393111

9

Establishment of a new animal model of focal subretinal fibrosis that resembles disciform lesion in advanced age-related macular degeneration.

Jo YJ, Sonoda KH, Oshima Y, Takeda A, Kohno R, Yamada J, Hamuro J, Yang Y, Notomi S, Hisatomi T, Ishibashi T. Jo YJ, et al. Among authors: oshima y. Invest Ophthalmol Vis Sci. 2011 Aug 1;52(9):6089-95. doi: 10.1167/iovs.10-5189. Invest Ophthalmol Vis Sci. 2011. PMID: 21051730

10

IL-27 inhibits pathophysiological intraocular neovascularization due to laser burn.

Hasegawa E, Oshima Y, Takeda A, Saeki K, Yoshida H, Sonoda KH, Ishibashi T. Hasegawa E, et al. Among authors: oshima y. J Leukoc Biol. 2012 Feb;91(2):267-73. doi: 10.1189/jlb.1110603. Epub 2011 Nov 1. J Leukoc Biol. 2012. PMID: 22045869

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,917 results

Search Page

Filters